Winter 2022 WashU Alumni Newsletter (pdf) (Links to an external site)
Tricuspid Regurgitation – Setting Standards for Diagnosis, Repair & Replacement. The Valve Team at Washington University School of Medicine is among the first in theworld to use a transfemoral transcatheter device for the treatment of severe tricuspidregurgitation (TR).
Diabetes, metabolic syndrome in mice treated with novel class of compounds (Links to an external site)
A study in mice — led by researchers at Washington University School of Medicine in St. Louis — shows that a new class of compounds the scientists developed can improve multiple aspects of metabolic syndrome. An increasingly common group of conditions that often occur together, metabolic syndrome includes type 2 diabetes, high cholesterol, fat buildup in the liver, and excess body fat, especially around the waist. This syndrome often leads to cardiovascular disease, the leading cause of death worldwide.
Popular heart failure drug no better than older drug in sickest patients (Links to an external site)
A new study led by researchers at Washington University School of Medicine in St. Louis suggests that a widely used heart failure drug named sacubitril/valsartan is no better than valsartan alone in patients with severe heart failure. The study also provides evidence that the treatment with valsartan may be slightly safer for patients with advanced heart failure.
Institute for Public Health names new director of the Global Health Center (Links to an external site)
The Institute for Public Health announces the appointment of Victor G. Dávila-Román, MD, as director of its Global Health Center. He was also named vice chair of global health in the Department of Medicine at the School of Medicine. Dávila-Román is professor of medicine in the cardiovascular division of the Department of Medicine, and a professor of anesthesiology and radiology at the School of Medicine. He earned his medical degree from the University of Puerto Rico, and has been affiliated with Washington University since 1986.
Radiation therapy reprograms heart muscle cells to younger state (Links to an external site)
New research from Washington University School of Medicine in St. Louis suggests that radiation therapy can reprogram heart muscle cells to what appears to be a younger state, fixing electrical problems that cause a life-threatening arrhythmia without the need for a long-used, invasive procedure.
Summer 2021 WashU Alumni Newsletter (pdf) (Links to an external site)
New Cardiovascular Division Chief Named – Sumanth D. Prabhu, MD, an internationally recognized expert in how immunity and inflammation contribute to heart failure, has been named the new Chief of the Cardiovascular Division in the Department of Medicine at Washington University School of Medicine. Upon joining our division on September 1, 2021,Dr. Prabhu also will […]
Research to explore how genes, other factors affect cardiometabolic disease risk (Links to an external site)
Researchers at Washington University School of Medicine in St. Louis have received a four-year, $8.8 million grant to ramp up research aimed at unraveling how an individual’s risks of cardiometabolic diseases, such as heart disease and Type 2 diabetes, are influenced by the interaction of specific genes with demographic and lifestyle factors.